Blue-chip companies rightfully make up the bulk of most people’s investment portfolios. These large-cap firms possess considerable industry leverage, as well as a vast sum of financial resources. Their status and importance to the underlying economy means that they are the least likely to crumble, regardless of external pressures. Ultimately, blue chips provide the confidence and stability....More>>>
When blue chips get too popular – like the five I’m going to show you today – these “safe stocks” can actually be dangerous to continue holding in your portfolio.
The problem with blue-chip stocks? Call it the “Curse of the Dow.” The Curse says a stock that joins the Dow Jones Industrial Average will essentially hit a wall, underperforming....More>>>
The word “growth” is the central word in the phrase Dividend Growth Investing, yet DGI often gets a bad rap as a stodgy method of saving for retirement. I think this misperception arises from the fact that some proponents of the strategy (who may be more focused on income than returns) require a certain minimum yield threshold for their investments. This, in turn, screens many of the....More>>>
&l;p&g;At first blush, you might think I&s;m a little late to the game with my annual &q;New Year&s;s Resolution&q; post. But my delay was actually a stroke of strategic genius. By waiting a few days to publish,&a;nbsp; I was allowing ample time for all of your &l;em&g;original&l;/em&g; goals for 2018 to fail miserably. And look at you now: It&s;s only January 5th, and you&s;re already back on gluten.....More>>>
Investment company Abrams Capital Management buys Time Warner Inc, PG&E Corp, Suburban Propane Partners LP, Keryx Biopharmaceuticals Inc, sells Barnes & Noble Education Inc during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Abrams Capital Management. As of 2017-12-31, Abrams Capital Management owns 20 stocks with a total value of $3 billion.....More>>>
The Florida citrus industry was already in big trouble even before Hurricane Irma started closing in. Now experts are worried that the storm could be the final straw that tips many growers into bankruptcy.
The problem until now has not been storms but a disease, known as citrus greening. It’s spread by an insect, and leaves the fruit green, bitter and unusable. As a result, Florida....More>>>
&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1051931270&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1051931270/960×0.jpg?fit=scale&q; data-height=&q;720&q; data-width=&q;960&q;&g; Shutterstock
My friend the blackjack pro does not feel bad about going into Wynn or Las Vegas Sands, counting the cards at the 21 table and leaving the premises with....More>>>
Apple, Alphabet and Samsung’s future forays into medical software could get speedier FDA approval thanks to a new program announced Tuesday.
The FDA is launching a pilot program that will give vetted tech companies pre-approval to work on medical software. The government agency oversees drug and medical device approval, in addition to food and health products. It has already pre-certified....More>>>
CEO of Palo Alto Networks Inc (NYSE:PANW) Mark D Mclaughlin sold 35,000 shares of PANW on 10/10/2017 at an average price of $149.7 a share. The total sale was $5.2 million.
Palo Alto Networks Inc develops and sells network and endpoint cybersecurity solutions to enterprise customers. Palo Alto Networks Inc has a market cap of $13.61 billion; its shares were traded at around $148.24 with and....More>>>
Many biotech stocks took a beating as price gouging from the likes of Valeant (Nitropress), Mylan (epi-pens), and Turing (Daraprim) became a political issue during last year’s presidential campaign. Consequently, we enter 2017 with many companies priced so attractively that they have become acquisition targets. Todd Hagopian outlines his top takeover targets.